相关实验视频

Updated: Jun 25, 2025

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

慢性阻塞性肺病患者的肠道病毒组变化

Yue Liu¹, Qingsong Huang², Zhenhua Zhuang³

¹State Key Laboratory of Southwestern Chinese Medicine Resources, School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Microbiology spectrum

|May 24, 2024

概括

肠道病毒组或肠道中的病毒群体在慢性阻塞性肺病 (COPD) 中发生变化. 在COPD患者中观察到病毒多样性的减少和特定的病毒功能,这表明肠道病毒组.

科学领域:

微生物组研究的研究.
病毒学病毒学
肺部医学肺部医学

背景情况:

慢性阻塞性肺病 (COPD) 是一个主要的全球健康问题.
人们越来越认识到肠道微生物在COPD中的作用,重点是细菌.
肠道病毒对COPD病原体的贡献仍然在很大程度上未被探索.

研究的目的:

为了研究COPD患者肠道病毒组的变化.
为了识别与COPD相关的疾病特异性病毒标志.
评估肠道病毒对COPD的诊断潜力.

主要方法:

来自92名中国受试者的便病毒样颗粒的深度元基因组测序.
细菌16S rRNA测序用于比较分析.
病毒丰富度,多样性,组成和功能的分析.

主要成果:

与健康人相比,COPD患者表现出较低的肠道病毒组丰富性和多样性.
特定的病毒物种 (例如,Clostridium菌体) 与肺功能正相关,在COPD中减少.
与细菌易感性和菌体与宿主相互作用相关的病毒功能在COPD中显著下降.
衰弱的病毒-细菌相互作用是COPD患者的特征.
肠道病毒组显示了COPD的高诊断性能 (AUC为88.7%).

结论:

肠道病毒组在COPD的发展和进展中发挥着重要作用.
肠道病毒组合和功能的变化与慢性慢性病相关.
肠道病毒组有可能成为COPD的诊断生物标志物.
准肠道病毒组可能为COPD提供新的治疗策略.

关键词:

慢性阻塞性肺病慢性阻塞性肺病诊断性表现的诊断性表现是什么我们的肠道微生物组.肠道病毒病毒ome 转基因组学是指转基因组学.

更多相关视频

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions

Published on: September 22, 2023

相关概念视频

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...